butyric acid has been researched along with Prostatic Neoplasms in 10 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypoacetylation on histone H3 of human prostate cancer cells has been described." | 1.43 | Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells. ( Cang, S; Chiao, JW; Liu, D; Ma, Y; Xu, X, 2016) |
| "Prostate cancer is a major cause of male cancer death." | 1.31 | Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. ( Brown, G; Campbell, MJ; Driver, PM; Edwards, CE; Engel, J; Moore, JS; Rashid, SF; Uskokovic, MR; Walker, E, 2001) |
| "Exposure of prostate cancer cell lines to PB reduces their DNA synthesis, leads to fragmentation of genomic DNA, and causes 50-60% of cells to undergo apoptosis." | 1.29 | Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. ( Ayyagari, SR; Campbell, PA; Carducci, MA; Chan-Tack, KM; Nelson, JB; Nelson, WG; Simons, JW; Sweatt, WH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paskova, L | 1 |
| Smesny Trtkova, K | 1 |
| Fialova, B | 1 |
| Benedikova, A | 1 |
| Langova, K | 1 |
| Kolar, Z | 1 |
| Mu, D | 1 |
| Gao, Z | 1 |
| Guo, H | 1 |
| Zhou, G | 1 |
| Sun, B | 1 |
| Maggio, A | 1 |
| Magli, A | 1 |
| Rancati, T | 1 |
| Fiorino, C | 1 |
| Valvo, F | 1 |
| Fellin, G | 1 |
| Ricardi, U | 1 |
| Munoz, F | 1 |
| Cosentino, D | 1 |
| Cazzaniga, LF | 1 |
| Valdagni, R | 1 |
| Vavassori, V | 1 |
| Weaver, EM | 1 |
| Zamora, FJ | 1 |
| Puplampu-Dove, YA | 1 |
| Kiessu, E | 1 |
| Hearne, JL | 1 |
| Martin-Caraballo, M | 1 |
| Cang, S | 1 |
| Xu, X | 1 |
| Ma, Y | 1 |
| Liu, D | 1 |
| Chiao, JW | 1 |
| Sonnemann, J | 1 |
| Gänge, J | 1 |
| Kumar, KS | 1 |
| Müller, C | 1 |
| Bader, P | 1 |
| Beck, JF | 1 |
| Carducci, MA | 1 |
| Nelson, JB | 1 |
| Chan-Tack, KM | 1 |
| Ayyagari, SR | 1 |
| Sweatt, WH | 1 |
| Campbell, PA | 1 |
| Nelson, WG | 1 |
| Simons, JW | 1 |
| Rashid, SF | 1 |
| Moore, JS | 1 |
| Walker, E | 1 |
| Driver, PM | 1 |
| Engel, J | 1 |
| Edwards, CE | 1 |
| Brown, G | 1 |
| Uskokovic, MR | 1 |
| Campbell, MJ | 1 |
| Halgunset, J | 1 |
| Lamvik, T | 1 |
| Espevik, T | 1 |
| Reese, DH | 1 |
| Gratzner, HG | 1 |
| Block, NL | 1 |
| Politano, VA | 1 |
1 review available for butyric acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Butyric Acid; Caspase 3; Caspases; | 2005 |
1 trial available for butyric acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
Topics: Acute Disease; Administration, Rectal; Analysis of Variance; Antineoplastic Agents, Hormonal; Butyri | 2014 |
8 other studies available for butyric acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Different effect of sodium butyrate on cancer and normal prostate cells.
Topics: Acetylation; Butyric Acid; Cell Line; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; H | 2013 |
Sodium butyrate induces growth inhibition and apoptosis in human prostate cancer DU145 cells by up-regulation of the expression of annexin A1.
Topics: Annexin A1; Apoptosis; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Respo | 2013 |
Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Topics: Butyric Acid; Calcium Channels, T-Type; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Prol | 2015 |
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
Topics: Acetylation; Amino Acid Sequence; Butyric Acid; Cell Line; Cell Line, Tumor; Chromatography, Liquid; | 2016 |
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.
Topics: Animals; Antineoplastic Agents; Apoptosis; Butyric Acid; DNA; Humans; Male; Phenylacetates; Phenylbu | 1996 |
Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
Topics: Antineoplastic Agents; Apoptosis; Butyric Acid; Calcitriol; Cell Cycle; Cholecalciferol; Cyclin-Depe | 2001 |
Butyrate effects on growth, morphology, and fibronectin production in PC-3 prostatic carcinoma cells.
Topics: Actin Cytoskeleton; Butyrates; Butyric Acid; Cell Division; Fibronectins; Fluorescent Antibody Techn | 1988 |
Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Butyrates; Butyric Acid; Cell Cycle; Cell Line; Fatty | 1985 |